DAPLAZOLE 60 MG CAPSULE

DAPLAZOLE 60 MG CAPSULE contains Dexlansoprazole as its active ingredient. Dexlansoprazole is a proton pump inhibitor (PPI) medication used to treat conditions related to excessive stomach acid production.

Mechanism of Action:

Dexlansoprazole works by inhibiting the proton pump in the stomach’s cells, reducing the production of acid. This action helps alleviate symptoms associated with acid-related conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.

Uses:

DAPLAZOLE 60 MG CAPSULE is prescribed for the following conditions:

• Gastroesophageal reflux disease (GERD): to relieve symptoms such as heartburn, regurgitation, and difficulty swallowing.
• Erosive esophagitis: to heal and prevent damage to the lining of the esophagus caused by stomach acid.
• Peptic ulcers: to promote healing and prevent recurrence of ulcers in the stomach or duodenum.

Administration:

DAPLAZOLE 60 MG CAPSULE is taken orally, usually once daily before a meal. The capsule should be swallowed whole and not crushed or chewed. The dosage and duration of treatment depend on the severity of the condition being treated and the patient’s response to therapy.

Side Effects:

Common side effects of DAPLAZOLE 60 MG CAPSULE may include:

• Headache
• Diarrhea
• Abdominal pain
• Nausea or vomiting
• Flatulence
• Constipation
• Dry mouth
• Dizziness

Precautions:

Before using DAPLAZOLE 60 MG CAPSULE, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. Long-term use of PPIs like Dexlansoprazole may be associated with an increased risk of bone fractures, vitamin B12 deficiency, and Clostridium difficile-associated diarrhea (CDAD). Patients should avoid abrupt discontinuation of Dexlansoprazole therapy without consulting their healthcare provider.

Contraindications:

DAPLAZOLE 60 MG CAPSULE is contraindicated in patients with a known hypersensitivity to Dexlansoprazole or any other components of the capsule. It should not be used in combination with drugs that are metabolized by the liver enzyme CYP2C19, such as certain benzodiazepines and antidepressants.

Conclusion:

DAPLAZOLE 60 MG CAPSULE, containing Dexlansoprazole, is a proton pump inhibitor used to treat acid-related conditions such as GERD, erosive esophagitis, and peptic ulcers. Patients should use this medication as directed by their healthcare provider and be aware of potential side effects. It is essential to discuss any concerns or questions about DAPLAZOLE with a healthcare professional.